Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bairui granules for acute upper respiratory tract infection in children
ChiCTR2000030787Phase 4Not yet recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Bairui granules in upper respiratory infection (URI) (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: Clinical recovery time at Day 7. Planned start Dec 2019; status: not yet recruiting.
02
Drugs
Bairui granules
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on ChiCTR2000030787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030787.